ITOS Insider Trading

Insider Ownership Percentage: 12.50%
Insider Buying (Last 12 Months): $38,650.00
Insider Selling (Last 12 Months): $0.00

iTeos Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at iTeos Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$10M$0$10MTotal Insider BuyingTotal Insider Selling

iTeos Therapeutics Share Price & Price History

Current Price: $5.70
Price Change: Price Decrease of -0.07 (-1.21%)
As of 04/3/2025 05:00 PM ET

This chart shows the closing price history over time for ITOS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$5.70Closing price on 04/03/25:

iTeos Therapeutics Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for iTeos Therapeutics (NASDAQ:ITOS)

97.16% of iTeos Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ITOS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$55Mbought$28MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$40M-$20M$0$20M$40MTotal InflowsTotal Outflows
iTeos Therapeutics logo
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984. The company was founded by Michel Detheux in April 2012 and is headquartered in Watertown, MA.
Read More on iTeos Therapeutics

Today's Range

Now: $5.70
Low: $5.47
High: $5.87

50 Day Range

MA: $7.10
Low: $5.63
High: $7.82

52 Week Range

Now: $5.70
Low: $5.47
High: $18.75

Volume

309,000 shs

Average Volume

458,596 shs

Market Capitalization

$217.71 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.43

Who are the company insiders with the largest holdings of iTeos Therapeutics?

iTeos Therapeutics' top insider shareholders include:
  1. Boxer Capital, Llc (Insider)
  2. Matthew Gall (CFO)
Learn More about top insider investors at iTeos Therapeutics.